Menu

Reconciliation of alternative performance measures


In CHF million
 
1.01.–30.09.2021
 
1.01.–30.09.2020
  Change
reported
  Change at constant
exchange rates
                 
Net revenue                
Net revenue   8,343   8,201   1.7%   1.3%
                 
Operating income before depreciation and amortisation (EBITDA)                
EBITDA   3,465   3,356   3.2%   2.9%
Gain from change in pension plan   (60)          
Additions to provisions for legal proceedings in Switzerland   52        
EBITDA adjusted   3,457   3,356   3.0%   2.7%
                 
Capital expenditure                
Capital expenditure in property, plant and equipment and intangible assets   1,594   1,621   –1.7%   –2.2%
Payments for indefeasible rights of use (IRU)   11   11   –%    
Capital expenditure   1,605   1,632   –1.7%   –2.2%

In CHF million
 
1.01.–30.09.2021
 
1.01.–30.09.2020
  Change
reported
             
Operating free cash flow proxy            
Cash flow from operating activities   2,908   3,032   (124)
Capital expenditure   (1,605)   (1,632)   27
Depreciation of right-of-use assets   (211)   (217)   6
Depreciation of indefeasible rights of use (IRU)   18   18  
Impairment losses of right-of-use assets     7   (7)
Change in deferred gain from the sale and leaseback of real estate   9   9  
Change in operating assets and liabilities   92   26   66
Change in provisions   (12)   27   (39)
Change in net defined benefit liabilities   22   (46)   68
Gain on sale of property, plant and equipment   5   8   (3)
Expense for share-based payments   (1)   (1)  
Revenue from finance leases   71   49   22
Interest received   (12)   (23)   11
Interest payments on financial liabilities   68   82   (14)
Dividends received   (1)   (15)   14
Income taxes paid   283   174   109
Operating free cash flow proxy   1,634   1,498   136
     
             
Free cash flow            
Cash flow from operating activities   2,908   3,032   (124)
Cash flow used in investing activities   (1,316)   (1,706)   390
Repayment of lease liabilities   (208)   (207)   (1)
Acquisition of subsidiaries, net of cash and cash equivalents acquired   25   30   (5)
Proceeds from equity-accounted investees   (135)     (135)
Expenses for shareholdings accounted for using the equity method   1   15   (14)
Purchase of other financial assets   13   122   (109)
Proceeds from other financial assets   (112)   (19)   (93)
Free cash flow   1,176   1,267   (91)